Division for Cancer Pharmacology – Young Investigators Symposium
Friday April 30, 2021
10:00 am
-
11:45 am
Eastern Time (ET)
View session on the EB Virtual Platform (EB registration required)
DCP
Chair :
Daniel Gustafson
Colorado State Univ
Andrew Thorburn
Univ of Colorado Anschutz Medical Campus
Christine Canman
Univ of Michigan Medical School
This session features oral presentations by young scientists doing research in cancer pharmacology who were selected from the submitted abstracts.
Speakers
Noor Abdulkareem
- University of Houston
A Novel Role of ADGRF1 (GPR110) in Promoting Cellular Quiescence and Chemoresistance in Human Epidermal Growth Factor Receptor 2-positive Breast Cancer
Pengfei Xu
- University of Pittsburgh
Intestinal Sulfation is Essential to Protect Against Colitis-Associated Colonic Carcinogenesis
Ethan Shelkey
- Wake Forest Graduate School
Immuno-Reactive Cancer Organoid Models to Examine Microbiome Metabolite Effects on Immune Checkpoint Blockade Efficacy
Eric Eisenmann
- The Ohio State University
Preclinical Characterization of TP-0903, a Novel Multikinase Inhibitor, in TP53 Mutant Acute Myeloid Leukemia
Qian Zhang
- Purdue University
RGS2 Inhibits Gαq-dependent Uveal Melanoma Cell Growth
Victor Hernandez
- Ohio State University
CRISPR/Cas9 Genome Editing of the Human Topoisomerase IIα Intron-19 5′ Splice Site Circumvents Etoposide Resistance in Human Leukemia K562 Cells